• Home
  • Courses
  • Medical Device Conformity Assessment Under the European Medical Devices Regulation (EU) 2017/745: Obtaining the CE Mark

Medical Device Conformity Assessment Under the European Medical Devices Regulation (EU) 2017/745: Obtaining the CE Mark

This seminar will provide essential guidance on how to undertake a successful conformity assessment process and subsequently apply (or continue to apply) the CE mark

29-30 Sep 2020

GBP 1,499
EUR 2,099
USD 2,338

Book now

Course overview

This course will show you how to plan for and undertake the conformity assessment process for your medical device to demonstrate that your product meets the enhanced requirements of the new Medical Devices Regulation (MDR).

As with the current Directive, the choice of conformity assessment route depends on the classification of the device. Once you have undergone a valid conformity assessment process and shown that your device has met the new requirements, you will be in a position to place a CE mark on your product which is your access to the European market.

The programme will provide essential guidance on how to undertake a successful conformity assessment process and subsequently
apply (or continue to apply) the CE mark. The importance of quality management systems, risk management, the use of standards and the current status of implementing acts, common specifications and published guidance will be a particular focus. This is
an excellent opportunity to understand the requirements and regulations and to discuss the complexities with two experts in this field.

Who should attend?

Medical device regulatory affairs professionals

  • New personnel to the medical device industry
  • Those transferring from the pharmaceutical industry to medical devices
  • Quality managers and quality assurance personnel
  • Business development professionals

Programme day one

Overview of the new MDR requirements

  • The General Safety and Performance Requirements (SPRs)
  • UDI and Eudamed
  • The post-market phase
  • Future developments
  • Implications of Brexit

The CE marking process under the MDR

  • What is the CE mark and what does it mean?
  • When do you need one?
  • When don’t you need one?

Deciding on the most appropriate assessment route for your product

  • Class I devices
  • Class IIa devices
  • Class IIb devices
  • Class III devices

Conformity assessment route workshop

Programme day two

Notified Bodies under the MDR and the role of Competent Authorities

  • Choosing your Notified Body (NB)
  • The role of Competent Authorities and other interested parties
  • What you need to do to prepare

Demonstrating compliance with harmonised standards

  • Current status of harmonised standards under the MDR
  • ISO 13485 covering quality management systems for medical device manufacturers
  • ISO 14971 covering risk management for medical devices
  • Other process-specific standards, such as those covering sterilisation
  • Standards for medical devices, active implantable medical devices

Quality management systems (QMS) and risk management workshop

Feedback and discussion

Clinical investigations

  • What is a clinical investigation?
  • When do you need to do one?

Feedback and discussion


Will Burton

Will Burton, Director of Russell Square Quality Representatives (RSQR) Ltd, is engaged in providing a range of consultancy and training services to the international medical device, pharmaceutical and biotechnology industry sectors. Prior to founding RSQA in 1995, Will was the Professional Services Manager of the Manufacturer Registration Scheme Business Unit of the UK Medical Devices Agency (now MHRA).

He is a Pharmacist, Medicinal Product Qualified Person, Medical Device Expert and registered international lead assessor. He managed the UK team of medical device expert assessors performing worldwide quality systems audits of medical device manufacturers against the requirements of the Department of Health’s Quality Systems Documents which formed the foundation for ISO 13485. He has very extensive auditing and quality systems experience and was closely involved in the selection, training and monitoring of UK Notified Bodies. He continues to perform QMS audits to ISO 13485 worldwide and has lectured internationally on related topics.

Paul Sim

Paul Sim, Regulatory Affairs Manager, BSi Group. Paul has worked in the healthcare industry for 34 years and is currently Project Managing BSI’s implementation of EU Commission Recommendation 2013/473/EU dealing with Unannounced Audits. Joining BSI in August 2010 leading the BSI effort working with the Saudi Food & Drug Authority on the implementation of the SFDA Medical Device Interim Regulations.

Previously he held senior RAQA leadership positions at Spacelabs Healthcare, Teleflex Medical, Smiths Medical, Ohmeda (formerly The BOC Group healthcare business)

Medical Device experience is across a very broad range of devices including: anaesthesia systems, patient monitors, vapourisers, ventilators, breathing circuits, single use sterile disposables and devices for re-use, infant warmers, incubators, steralisers, autoclaves, operating tables, infusion pumps and associated disposables, urinary catheters, surgical instruments, diagnostic cardiology etc.

Paul is a member of the Association of British Healthcare Industries (ABHI) Technical Policy Group and is Convenor of the ABHI ISO TC 210 Mirror Group. Convenor of the BSI Committee, which monitors all of the work undertaken by ISO TC 210, and Convenor of the BSI Sub-committee dealing with Quality Systems. As UK Delegation Leader to ISO TC 210, Paul is also actively involved in the work of national, European and international standards’ committees, dealing with revisions to the ISO 9000 series, ISO 13485, ISO 14971, ISO 15223 and others. He is Deputy Chairman and Council Member of Barema (British Anaesthetic & Respiratory Manufacturers Association), also a Member of the Association of Anaesthetists of Great Britain and Ireland (AAGBI) Safety Committee.

Book now

29-30 Sep 2020
29-30 Sep 2020 Cavendish Hotel, London GBP 1,499.00
EUR 2,099.00
USD 2,338.00
+ VAT @ 20.00%
Enrol now

Previous customers include...

  • CSL Behring AG
  • Halyard Belgium BVBA (Avanos)
  • Medigen Regulatory Limited
  • Presspart
  • Ramsay MD-Regs Ltd
  • Saudi Food and Drug Authority

The content, presentations and workshops were delivered by experts in the field, who engaged the delegates and involved them in discussions.

Tina Aspinall, Consultant, Medigen Regulatory Limited

Very good and would recommend. Paul and Will both had very good knowledge of the MDR and complimented each other very well. Paul and Will also took time to answer individual questions.

Paul Fitton, Regulatory Affairs Specialist, Presspart

Very good speaks with a lot of experience.

Jens Martens , Regulatory Affairs Officer , Halyard Belgium BVBA (Avanos)